Hybrid Pharma Today Announced That Alexandra Richards Has Joined The Company as VP of Worldwide Marketing

Press Release New York City Rockefeller Center NY York Times & Hybrid Medical Media: Robert Graham Ph.D. Reports

Hybrid Pharma Today announced that Alexandra Richards has joined the company as VP of Worldwide Marketing

Houston (AP) A Hybrid Pharmaceutical, the Genomics Biotech Engineering Company, today announced that Alexandra Richards has joined the company as vice president of worldwide marketing. In

her new role, Richards oversees the strategic management of global marketing initiatives for Hybrid Pharma®. Richards brings more than 20 years of experience in marketing management with expertise in developing and managing go-to-market strategies and initiatives, brand management, channel marketing and enablement, lead generation and field marketing.

 Brought To You By gloStream

The Hybrid Pharmaceutical Integrated Clinical Research Suite (HPIC) offers a global, integrated set of solutions to help life sciences companies of all types and sizes manage their entire clinical development process — from Phase I through regulatory

submission, post-approval trials and pharmacy covigilance. With the ICRS, organizations can rely on a single solution provider to help them meet drug development needs in today’s challenging environment.

As Hybrid Pharma looks to extend its leadership in Biotech Engineering to new products and markets, including cloud storage, Richards is leading the effort to communicate the company’s vision and strategy and to develop and implement go-to-market activities. Additionally, Richards is responsible for extending Hybrid Pharma’s brand equity and accelerating growth with its partners through Hybrid Pharma partner program enablement and recruitment initiatives. “Alex’s proven ability to develop expansion strategies in new and existing market segments will enable her to align Hybrid Pharma marketing efforts for the company’s next round of growth,” said Elizabeth Jones, senior vice president, marketing and business development at Hybrid Pharma. “We look forward to enhancing our overall brand and market leadership position worldwide with Alex’s direction and collective experience in sales, marketing and communications.” Prior to joining Hybrid Pharma, Richards was senior vice president of worldwide marketing at MNM BRAND STREET, where she oversaw all outbound marketing strategy

Brought To You By Antiques of River Oaks Houston,Txcomponents, including company branding and communications, product marketing, the company’s partner program, and the management of all aspects of online and offline demand generation. Prior to MNM, Richards was Digital Marketing Director at GREY WORLDWIDE/G2, where she architected and implemented the company’s systems integrators go-to-market strategy. “With the increasing adoption of consolidation, virtualization, and cloud-based services, there is a bright future ahead for Hybrid Pharma,” said Richards. “I look forward to leading the effort to expand the market opportunities for Hybrid Pharma products and building go-to-market strategies that enable organizations to realize optimal IT performance.” Forward Looking Statements This press release contains forward-looking statements, including statements relating to the expected demand for Hybrid Pharma's products and services, statements regarding Hybrid Pharma’s growth and market opportunities, and statements relating to Hybrid

Pharma’s ability to meet the needs of distributed organizations. These forward-looking statements involve risks and uncertainties, as well as assumptions that, if they do not fully materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. Hybrid Pharma reserves the right to modify future product plans at any time. About Hybrid Pharma Hybrid Pharma is a leading global bio/pharmaceutical services organization that helps clients expedite time-to-market through our development and launch services. These include a broad range of clinical development capabilities, integrated advanced technologies, regulatory affairs consulting, and commercialization services is available at www.Hybrid Pharma.com.